Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +22.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 101–107 of 107 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00516750	Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin	terminated	Phase 2	100	Kyoto UniversityOTHER	1	Jul 10, 2013	clinicaltrials
NCT00004856	Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium	terminated	Phase 2	40	National Cancer Institute (NCI)NIH	1	May 3, 2013	clinicaltrials